Veracyte (VCYT) EPS (Weighted Average and Diluted): 2019-2025
Historic EPS (Weighted Average and Diluted) for Veracyte (VCYT) over the last 6 years, with Sep 2025 value amounting to $0.24.
- Veracyte's EPS (Weighted Average and Diluted) rose 26.32% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.38, marking a year-over-year increase of 371.43%. This contributed to the annual value of $0.31 for FY2024, which is 130.39% up from last year.
- Per Veracyte's latest filing, its EPS (Weighted Average and Diluted) stood at $0.24 for Q3 2025, which was up 2,500.00% from -$0.01 recorded in Q2 2025.
- In the past 5 years, Veracyte's EPS (Weighted Average and Diluted) ranged from a high of $0.24 in Q3 2025 and a low of -$0.66 during Q1 2021.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.04, with a median of -$0.01 in 2025.
- In the last 5 years, Veracyte's EPS (Weighted Average and Diluted) tumbled by 660.00% in 2023 and then spiked by 550.00% in 2025.
- Veracyte's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.14 in 2021, then skyrocketed by 64.29% to -$0.05 in 2022, then tumbled by 660.00% to -$0.38 in 2023, then spiked by 115.79% to $0.06 in 2024, then rose by 26.32% to $0.24 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.24 in Q3 2025, compared to -$0.01 in Q2 2025 and $0.09 in Q1 2025.